Targeting CSC Dormancy

Cancer stem cells (CSCs) can enter a dormant state, allowing them to evade treatments and later reinitiate tumor growth. This track focuses on understanding the mechanisms that regulate CSC dormancy, including signals from the microenvironment and intrinsic genetic factors. Researchers explore how dormant CSCs resist conventional therapies, which typically target actively dividing cells. Developing therapies that can either awaken dormant CSCs, making them vulnerable to treatment, or eliminate them while dormant, could significantly improve long-term survival rates for cancer patients. This research aims to prevent tumor recurrence by targeting the CSCs that remain dormant but capable of causing relapse.

    Related Conference of Targeting CSC Dormancy

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Targeting CSC Dormancy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in